FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizonal rule

FDA Rule Requires Bar Codes on Drugs and Blood to Help Reduce Errors

As part of a wide-ranging effort to improve patient safety, on Feb. 25, 2004, FDA finalized a rule requiring bar codes on the labels of thousands of human drugs and biological products. The measure aims to protect patients from preventable medication errors by helping ensure that health professionals give patients the right drugs at the appropriate dosages.

The bar codes -- similar to those on food packages and other consumer goods -- will be required on most prescription drugs and certain over-the-counter drugs. The rule also requires machine-readable information on container labels of blood and blood components intended for transfusion.

FDA estimates that the rule will help prevent nearly 500,000 adverse events and transfusion errors while saving $93 billion in health costs over 20 years.

In March 2003, FDA also proposed a rule designed to improve reporting requirements for safety problems involving medicines.

For more information on bar codes, see:

HHS Press Release (February 25, 2004)

Final Rule: Bar Code Label Requirement For Human Drug Products and Blood (February 25, 2004)

Fact Sheet (February 25, 2004)

HHS Press Release (March 13, 2003)

Proposed Rule (PDF 246 KB) (March 14, 2003)

Federal Register: Safety Reporting Requirements for Human Drug and Biological Products (PDF) (March 14, 2003)

 

horizonal rule